Assessment of risk awareness, beliefs and medicine use behaviour among women receiving antenatal careat a Nigerian tertiary hospital Évaluation de la perception des risques, des croyances et des comportements liés à l'utilisation des médicamentschez les femmes bénéficiant de soins prénataux dans un centre hospitalier universitaire nigérian
Main Article Content
Abstract
Background: Drug use during pregnancy presents a special concern due to the threat of potential teratogenic effects and physiologic adjustments in the mother.
Objectives: To assess the risk awareness, beliefs and medicine use behaviour among pregnant women.
Methods: A descriptive cross-sectional study carried out among women receiving antenatal care at the University of Uyo Teaching Hospital (UUTH). A systematic sampling technique was used in recruiting eligible participants into the study. Data on the clinical characteristics of the respondents was obtained from their respective case notes. Participants' awareness of the risks associated with the use of medicines in pregnancy; their beliefs and medicine use behaviour was obtained using a suitably designed questionnaire. Quantitative data was analysed using the SPSS computer package. Descriptive statistics and inferential statistics were used where applicable with statistical significance set at p < 0.05.
Results: One hundred and eighty-seven women participated in this study. The mean risk awareness score was 5.74 (SD = ± 1.64; Max. = 8), while the mean beliefs score and medicine use behaviour score were 4.16 (SD = ± 1.12; Max. = 5) and 5.43 (SD = ± 1.45; Max. = 7) respectively. The respondents' risk awareness score was a predictor of their beliefs score (B = 0.227; p = 0.002); and medicine use behaviour score (B = 0.168; p = 0.022).
Conclusion: We identified gaps in the risk awareness, beliefs and medicine use behaviour among the women studied. The awareness of the risks associated with the use of medicines in pregnancy was significantly associated with the beliefs regarding the use of medicines in pregnancy as well as medicine use behaviour among the women. There is need for targeted educational initiatives and enhanced communication from healthcare providers to promote safer medication practices during pregnancy.
Résumé
Contexte : La prise de médicaments pendant la grossesse suscite une préoccupation particulière en raison du risque d'effets tératogènes potentiels et des adaptations physiologiques chez la mère.
Objectifs : Évaluer la perception des risques, les croyances et les comportements liés à l'utilisation des médicaments chez les femmes enceintes.
Méthodes : Une étude descriptive transversale a été menée auprès de femmes bénéficiant de soins prénataux au Centre hospitalier universitaire d'Uyo (UUTH). Un échantillonnage systématique a été utilisé pour recruter les participantes éligibles. Les données relatives aux caractéristiques cliniques des participantes ont été extraites de leurs dossiers médicaux. La perception des risques associés à l'utilisation des médicaments pendant la grossesse chez les participantes, leurs croyances et leur comportement d'utilisation des médicaments ont été recueillis à l'aide d'un questionnaire conçu à cet effet. Les données quantitatives ont été analysées à l'aide du logiciel SPSS. Des statistiques descriptives et inférentielles ont été utilisées le cas échéant, le seuil de signification statistique étant fixé à p < 0,05.
Résultats: Cent quatre-vingt-sept femmes ont participé à cette étude. Le score moyen de de perception des risques était de 5,74 (écart-type = ± 1,64 ; score maximal = 8), tandis que les scores moyens de croyances et de comportements liés à l'utilisation des médicaments étaient respectivement de 4,16 (écart-type = ± 1,12 ; score maximal = 5) et de 5,43 (écart-type = ± 1,45 ; score maximal = 7). Le score de perception des risques des participantes était un prédicteur de leur score de croyances (B = 0,227 ; p = 0,002) et de leur score de comportements liés à l'utilisation des médicaments (B = 0,168 ; p = 0,022).
Conclusion : Nous avons constaté des lacunes dans la perception des risques, les croyances et les comportements liés à l'utilisation des médicaments chez les femmes étudiées. La perception des risques associés à l'utilisation de médicaments pendant la grossesse était significativement corrélée aux croyances concernant cette utilisation, ainsi qu'au comportement d'utilisation des médicaments chez les femmes. Il est nécessaire de mettre en place des initiatives éducatives ciblées et d'améliorer la communication de la part des professionnels de la santé afin de promouvoir des pratiques plus sûres en matière de prise de médicaments pendant la grossesse.
Downloads
Article Details
Issue
Section

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
How to Cite
Share
References
1.Haque MA, Ananna RS, Hasan N, Aktar MF, Zakaria AFM (2024). Social norms and maternal health information-seeking behavior among adolescent girls: A qualitative study in a slum of Bangladesh. Public Library of Science One 19 (12): e0315002. https://doi.org/10.1371/journal.pone.0315002.
2.Higginbottom GM, Safipour J, Mumtaz Z, Chiu Y,Paton P, Pillay J. (2013). "I have to do what I believe": Sudanese women's beliefs and resistance to hegemonic practices at home and during experiences of maternity care in Canada. BMC Pregnancy and Childbirth 13:51 (Supp 2).https://doi.org/10.1186/1471-2393-13-51.
3. Kisa A, Kisa S (2025). Health conspiracy theories: a scoping review of drivers, impacts, and countermeasures. International Journal of Equity in Health 24(1):93. https://doi.org/10.1186/s12939-025-02451-0.
4.Glendinning E, Spiers J, Smith JA, Anderson J, Campbell LJ, Cooper V, Horne R (2019). A Qualitative Study to Identify Perceptual Barriers to Antiretroviral Therapy (ART) Uptake and Adherence in HIV Positive People from UK Black African and Caribbean Communities. AIDS and Behavior 23(9): 2514-2521. https://doi.org/10.1007/s10461-019-02670-x.
5.Keller MS, Mosadeghi S, Cohen ER, Kwan J, Spiegel BMR (2018). Reproductive Health and Medication Concerns for Patients with Inflammatory Bowel Disease: Thematic and Quantitative Analysis Using Social Listening. Journal of Medical Internet Research 20(6):e206.https://doi.org/10.2196/jmir.9870.
6.Zhang HY, Andiman SE, D'Ascanio AM, Grimes CL, Pape DM (2026). Barriers to Effective Treatment of Genitourinary Syndrome of Menopause: A ualitative Study on Patient Perspectives on Vaginal Estrogen. International Urogynecology Journal 37(2):367-374. https://doi.org/10.1007/s00192-025-06246-3.
7.Babazadeh T, Ranjbaran S, Pourrazavi S, Latifi A, Maleki CK (2024). Impact of health literacy and illness perception on medication adherence among older adults with hypertension in Iran: a cross- sectional study. Frontiers in Public Health 27:12:1347180.https://doi.org/10.3389/fpubh.2024.1347180.
8.Selvakumar D, Sivanandy P, Ingle PV, Theivasigamani K (2023). Relationship between Treatment Burden, Health Literacy, and Medication Adherence in Older Adults Coping with Multiple Chronic Conditions. Medicina 59(8):1401. https://doi.org/10.3390/medicina59081401.
9.Venditti V, Bleve E, Morano S, Filardi T (2023). Gender-Related Factors in Medication Adherence for Metabolic and Cardiovascular Health. Metabolites 13(10):1087. https://doi.org/10.3390/metabo13101087.
10.Obi OC, Anosike C (2023). A cross-sectional study on the knowledge, attitude, and practice of pregnant women regarding medication use and restriction during pregnancy. Exploratory Research in Clinical and Social Pharmacy 11:100308. https://doi.org/10.1016/j.rcsop.2023.100308.11.
11. Apuulison DF, Nabawanuka B, Muhoozi M, Aryampa J, Irumba P, Katsomyo E, Asiimwe M, Epuitai J, Akugizibwe P, George W, Rubaihayo J. (2025). Enablers of and barriers to ART adherence among female sex workers in mid-western Uganda: a qualitative study. AIDS Research and Therapy (1):4. https://doi.org/10.1186/s12981-025-00698-9.
12. Farhat M (2024). Exploring Health-Seeking Behaviors and Coping Strategies: A Qualitative Study of Women in Urban Slum Areas of Lahore, akistan. Journal of Sociological Research and Innovation 2(1):01-21. https://doi.org/10.32350/sri.21.01.
13. Cipta DA, Andoko D, Theja A, Utama AVE, Hendrik H, William DG, Reina N, Handoko MT, Lumbuun N (2024). Culturally sensitive patient-centered healthcare: a focus on health behavior modification in low and middle-income nations-insights from Indonesia. Frontiers in Medicine 11:1353037. https://doi.org/10.3389/fmed.2024.1353037.
14. Feinberg IZ, Owen-Smith A, O'Connor MH, Ogrodnick MM, Rothenberg R, Eriksen MP. (2021). Strengthening Culturally Competent Health Communication. Health Security 19(S1):S41-S49. https://doi.org/10.1089/hs.2021.0048.
15. "Uyo, Nigeria Metro Area Population 1950-2024". www.macrotrends.net. Accessed on March 10, 2026.
16. Tefera YG, Gebresillassie BM, Getnet MA, Belachew SA (2020). Beliefs and Risk Awareness on Medications Among Pregnant Women Attendingthe Antenatal Care Unit in Ethiopia University Hospital. Overestimating the Risks Is Another Dread. Frontiers in Public Health 8:28. doi: 10.3389/fpubh.2020.00028.
17. Buhimschi CS, Weiner CP (2009). Medications in Pregnancy and Lactation: Part 1. Teratology. Obstetrics and Gynecology 113(1): 166-188.
https://doi.org/10.1097/aog.0b013e31818d686c.
18. Ceulemans M, Lupattelli A, Nordeng H, Odalovic M, Twigg M, Foulon V (2019). Women's Beliefs About Medicines and Adherence to Pharmacotherapy in Pregnancy: Opportunities for Community Pharmacists. Current Pharmaceutical Design 25(5):469-482. https://doi.org/10.2174/1381612825666190321110420.
19. Gallitelli, V., Franco, R., Guidi, S., Puri, L., Parasiliti, M., Vidiri, A., Eleftheriou, G., Perelli, F., & Cavaliere, A. F. (2024). Depression Treatment in Pregnancy: Is It Safe, or Is It Not? International Journal of 20.21.22.23.24.25.26.27.28.Environmental Research and Public Health 21(4):404. https://doi.org/10.3390/ijerph21040404.
Matsui D (2011). Adherence with Drug Therapy in Pregnancy. Obstetrics and Gynecology International 2012:2012:796590. https://doi.org/0.1155/2012/796590.
Qasqas SA, Mcpherson C, Frishman WH, Elkayam U (2004). Cardiovascular pharmacotherapeutic considerations during pregnancy and lactation. Cardiology in Review 12(4):201-221. https://doi.org/10.1097/01.crd.0000102420.62200. e1.
Sachdeva P, Patel B, Patel B (2009). Drug Use in Pregnancy; a Point to Ponder! Indian Journal of Pharmaceutical Sciences 71(1):1-7. https://doi.org/10.4103/0250-474x.51941.
Schwarz EB, Santucci A, Borrero S, Akers AY, Nikolajski C, Gold MA (2009). Perspectives of primary care clinicians on teratogenic risk counseling. Birth Defects Research Part A - Clinical Molecular Teratology 85(10):858-863. https://doi.org/10.1002/bdra.20599.
Albassam A, Awad A (2018). Community pharmacists' services for women during pregnancy and breast feeding in Kuwait: a cross-sectional study. BMJ Open 8(1):e018980. https://doi.org/10.1136/bmjopen-2017-018980.
Leung HY, Saini B, Ritchie HE (2018). Medications and pregnancy: The role of community pharmacists - A descriptive study. Public Library of Science ONE 13(5):e0195101. https://doi.org/10.1371/journal.pone.0195101.
Lynch MM, Amoozegar JB, Mcclure EM, Squiers LB, roussard CS, Lind JN, Polen KN, Frey MT, Gilboa SM, Biermann J (2017). Improving Safe Use of Medications During Pregnancy: The Roles of Patients, Physicians, and Pharmacists. Qualitative Health Research 27(13):2071-2080.https://doi.org/10.1177/1049732317732027.
Sinclair M, Lagan BM, Dolk H, Mccullough JEM (2018). An assessment of pregnant women's knowledge and use of the Internet for medication safety information and purchase. Journal of Advanced Nursing 74(1):137-147. https://doi.org/10.1111/jan.13387.
Alipour F, Peiravian F, Mehralian G (2018). Perceptions, experiences and expectations of physicians regarding the role of pharmacists in low- income and middle-income countries: the case of Tehran hospital settings. BMJ Open 8(2):e019237.https://doi.org/10.1136/bmjopen-2017-019237.
29. Resnik DB, Ranelli PL, Resnik SP (2000). The conflict between ethics and business in community pharmacy: what about patient counseling? Journal of Business Ethics 28(2):179-186. https://doi.org/10.1023/a:1006280300427.
30. Surur AS, Getachew E, Teressa E, Hailemeskel B, Getaw NS, Erku DA (2017). Self-reported and actual involvement of community pharmacists in patient counseling: a cross-sectional and simulated patient study in Gondar, Ethiopia. Pharmacy Practice, 15(1):890. https://doi.org/10.18549/pharmpract.2017.01.890.
31. Rafie S, Stone RH, Wilkinson TA, Borgelt L, El-Ibiary SY, Ragland D (2017). Role of the community pharmacist in emergency contraception counseling and delivery in the United States: current trends and future prospects. Integrated Pharmacy Research Practice 6(9):99-108.
https://doi.org/10.2147/iprp.s99541.
32. Cavaco A, Roter D (2010). Pharmaceutical consultations in community pharmacies: utility of the Roter Interaction Analysis System to study pharmacist-patient communication. International Journal of Pharmacy Practice 8(3):141-148. https://doi.org/10.1211/ijpp.18.03.0003.
33. Farley TM, Shelsky C, Powell S, Farris KB, Carter BL (2014). Effect of clinical pharmacist intervention on medication discrepancies following hospital discharge. International Journal of Clinical Pharmacy 36(2):430-437. https://doi.org/10.1007/s11096-014-9917-x.
34. Knoer SJ, Eck AR, Lucas AJ (2016). A review of American pharmacy: education, training, technology, and practice. Journal of Pharmaceutical Health and Care Sciences 2(1):32. https://doi.org/10.1186/s40780-016-0066-3.
35. Sarangarm P, London MS, Snowden SS, Dilworth TJ, Koselke LR, Sanchez CO, D'Angio R, Ray G (2013). Impact of Pharmacist Discharge Medication Therapy Counseling and Disease State Education. American Journal of Medical Quality 28(4):292-300. https://doi.org/10.1177/1062860612461169.
36. Abduelkarem AR, Mustafa H (2017). Use of Over-the-Counter Medication among Pregnant Women in Sharjah, United Arab Emirates. Journal of Pregnancy 2017:4503793. https://doi.org/10.1155/2017/4503793.
37. Atmadani RN, Nkoka O, Yunita SL, Chen YH (2020). Self-medication and knowledge among pregnant 152 West African Journal of Pharmacy (2026) 37 (2) et al women attending primary healthcare services in Malang, Indonesia: a cross-sectional study. BMC Pregnancy and Childbirth 20(1):42. https://doi.org/10.1186/s12884-020-2736-2.
38. Refuerzo JS, Blackwell SC, Sokol RJ, Lajeunesse L, Firchau K, Kruger M, Sorokin Y (2005). Use of Over- the-Counter Medications and Herbal Remedies in Pregnancy. American Journal of Perinatology 22(06):321-324. https://doi.org/10.1055/s-2005-873235.
39. Dominic A, Ogundipe A, Ogundipe O (2019). Determinants of Women Access to Healthcare Services in Sub-Saharan Africa. The Open Public Health Journal 12(1):504-514. https://doi.org/10.2174/1874944501912010504.
40. Raghav SV, Padmavathi SM. (2024). The Role of Socioeconomic Factors in Shaping Health Outcomes among Vulnerable Populations. South Eastern European Journal of Public Health 1422-1432. https://doi.org/10.70135/seejph.vi.2086.
41. El-Khatib Z, Odusina EK, Ghose B, Yaya S (2020). Patterns and Predictors of Insufficient Antenatal Care Utilization in Nigeria over a Decade: A Pooled Data Analysis Using Demographic and Health Surveys. International Journal of Environmental Research and Public Health 17(21):8261.https://doi.org/10.3390/ijerph17218261.
42. Imo CK (2022). Influence of women's decision-making autonomy on antenatal care utilisation and institutional delivery services in Nigeria: evidence from the Nigeria Demographic and Health Survey 2018. BMC Pregnancy and Childbirth 22(1):141. https://doi.org/10.1186/s12884-022-04478-5.
43. Kim MK, Lee SM, Bae SH, Kim HJ, Lim NG, Yoon SJ, Lee JY, Jo MW (2018). Socioeconomic status can affect pregnancy outcomes and complications, even with a universal healthcare system. International Journal of Equity in Health 17(1):2. https://doi.org/10.1186/s12939-017-0715-7.
44. Wang H, Frasco E, Takesue R, Tang K (2021). Maternal education level and maternal healthcare utilization in the Democratic Republic of the Congo: an analysis of the multiple indicator cluster survey 2017/18. BMC Health Services Research 21(1):850.https://doi.org/10.1186/s12913-021-06854-x.
45. Amundsen S, Øvrebø TG, Amble NMS, Poole AC, Nordeng H (2019). Risk perception, beliefs about medicines and medical adherence among pregnant and breastfeeding women with migraine: findings from a cross-sectional study in Norway. BMJ Open 9(2):e026690. https://doi.org/10.1136/bmjopen-2018-026690.46.
Vitale SG, Laganà AS, Muscatello MRA, La Rosa VL, Currò V, Pandolfo G, Zoccali RA, Bruno A (2016). Psychopharmacotherapy in Pregnancy and Breastfeeding. Obstetrical and Gynecological Survey 71(12):721-733. https://doi.org/10.1097/ogx.0000000000000369.
47. Ahmed SM, Sundby J, Aragaw YA, Abebe F (2020). Self-Medication and Safety Profile of Medicines Used among Pregnant Women in a Tertiary Teaching Hospital in Jimma, Ethiopia: A Cross- Sectional Study. International Journal of Environmental Research and Public Health 17(11):3993. https://doi.org/10.3390/ijerph17113993.
48. Wolgast E, Lindh-Åstrand L, Lilliecreutz C (2019). Women's perceptions of medication use during pregnancy and breastfeeding-A Swedish cross- sectional questionnaire study. Acta Obstetricia et Gynecologica Scandinavica 98(7):856-864. https://doi.org/10.1111/aogs.13570.
49. Medina-Córdoba M, Cadavid S, Pérez-Acosta AM, Amaya-Giraldo V (2021). Factors that Facilitate and Hinder the Comprehension of Patient Information Leaflets (PILs): A Brief Scoping Review. Frontiers in Pharmacology 12:740334. https://doi.org/10.3389/fphar.2021.740334.
50. Dathe K, Schaefer C (2018). Drug safety in pregnancy: the German Embryotox institute. European Journal of Clinical Pharmacology 74(2):171-179. https://doi.org/10.1007/s00228-017-2351-y.
51. Herber OR, Gies V, Schwappach D, Thürmann P, Wilm S (2014). Patient information leaflets: informing or frightening? A focus group study exploring patients' emotional reactions and subsequent behavior towards package leaflets of commonly prescribed medications in family practices. BMC Family Practice 15(1):163. https://doi.org/10.1186/1471-2296-15-163.
52. Pelizzari N (2024). The Challenges for EU User Testing Policies for Patient Information Leaflets. International Journal of Environmental Research and Public Health 21(10):1301. https://doi.org/10.3390/ijerph21101301.
53. França AS, Pirkle CM, Sentell T, Velez MP, Domingues MR, Bassani DG, Câmara SMA (2020). Evaluating Health Literacy among Adolescent and Young Adult Pregnant Women from a Low-Income Area of Northeast Brazil. International Journal of Environmental Research and Public Health 17(23):8806. use in antenatal care https://doi.org/10.3390/ijerph17238806.
54. Guler DS, Sahin S, Ozdemir K, Unsal A, Yuvac? HU (2021). Health literacy and knowledge of antenatal care among pregnant women. Health and Social Care in the Community 29(6):1815-1823. https://doi.org/10.1111/hsc.13291.
55. Rafat N, Bakouei F, Adib-Rad H, Nikbakht HA, Bakouei S (2025). Predicting the Health-Promoting Lifestyle Profile of Pregnant Women Based on Their Health Literacy Levels: A Cross-Sectional Study. Nursing Open, 12(1):70136. https://doi.org/10.1002/nop2.70136.
56. Beyene KG, Beza SW (2018). Self-medication practice and associated factors among pregnant women in Addis Ababa, Ethiopia. Tropical Medicine and Health 46(1):10. https://doi.org/10.1186/s41182-018-0091-z.
57. Marwa KJ, Njalika A, Ruganuza D, Katabalo D, Kamugisha E (2018). Self-medication among pregnant women attending antenatal clinic at Makongoro health centre in Mwanza, Tanzania: a challenge to health systems. BMC Pregnancy and Childbirth 18(1):16. https://doi.org/10.1186/s12884-017-1642-8.
58. Goruntla N, Ganzi N, Otturu M, Vaddi SN, Mood SL, Suchitra MJ, Veerabhadrappa KV, Ezeonwumelu JOC, Bukke SPN (2025). Knowledge, Attitude, and Practice Toward Medication Use During Pregnancy: A Hospital-Based Cross-Sectional Survey. Journal of Obstetrics and Gynaecology of India 75(Suppl 1):317-326. https://doi.org/10.1007/s13224-024-01984-8.
59. Oechsle A, Wensing M, Ullrich C, Bombana M (2020). Health Knowledge of Lifestyle-Related Risks during Pregnancy: A Cross-Sectional Study of Pregnant Women in Germany. International Journal of Environmental Research and Public Health 17(22):8626. https://doi.org/10.3390/ijerph17228626.
60. Olesen C, Thrane N, Henriksen TB, Ehrenstein V, Olsen J (2006). Associations between socio- economic factors and the use of prescription medication during pregnancy: a population-based study among 19,874 Danish women. European Journal of Clinical Pharmacology 62(7):547-553.https://doi.org/10.1007/s00228-006-0119-x.
61. Thomas NJ, Middleton PF, Crowther CA (2008). Oral and dental health care practices in pregnant women in Australia: a postnatal survey. BMC Pregnancy and Childbirth 8(1):13. https://doi.org/10.1186/1471-2393-8-13.62.
Zewdie T, Azale T, Shimeka A, Lakew AM (2018). Self-medication during pregnancy and associated factors among pregnant women in Goba town, southeast Ethiopia: a community based cross sectional study. BMC Research Notes 11(1):713. https://doi.org/10.1186/s13104-018-3821-8.
63. Lupattelli A, Spigset O, Nordeng H (2014). Adherence to medication for chronic disorders during pregnancy: results from a multinational study. International Journal of Clinical Pharmacy 36(1):145-153. https://doi.org/10.1007/s11096-013-9864-y.
64. Mellins CA, Chu C, Malee K, Allison S, Smith R, Harris L, Higgins A, Zorrilla C, Landesman S, Serchuck L, Larussa P (2008). Adherence to antiretroviral treatment among pregnant and postpartum HIV- infected women. AIDS Care 20(8):958-968. https://doi.org/10.1080/09540120701767208.
65. Frank AS, Lupattelli A, Matteson DS, Nordeng H (2018). Maternal use of thyroid hormone replacement therapy before, during, and after pregnancy: agreement between self-report and prescription records and group-based trajectory modeling of prescription patterns. Clinical Epidemiolology 10:1801-1816. https://doi.org/10.2147/clep.s175616.
66. Saadati N, Afshari P, Boostani H, Beheshtinasab M, Abedi P, Maraghi E (2021). Health anxiety and related factors among pregnant women during the COVID-19 pandemic: a cross-sectional study from Iran. BMC Psychiatry 21(1):95. https://doi.org/10.1186/s12888-021-03092-7.
67. Splinter MY, Sagraves R, Nightengale B, Rayburn WF (1997). Prenatal use of medications by women giving birth at a university hospital. Southern Medical Journal 90(5):498-502. https://doi.org/10.1097/00007611-199705000-00006.
68. Heaman MI, Gupton AL (2009). Psychometric testing of the Perception of Pregnancy Risk Questionnaire. Research in Nursing & Health 32(5): 93-503. https://doi.org/10.1002/nur.20342.
69. Jones MA, Whitaker K, Wallace M, Gibbs BB (2021). Demographic, Socioeconomic, and Health-Related Predictors of Objectively Measured Sedentary Time and Physical Activity During Pregnancy. Journal of Physical Activity and Health 18(8):957-964. https://doi.org/10.1123/jpah.2021-0097.
70. Ban L, West J, Gibson JE, Fiaschi L, Sokal R, Doyle P, Hubbard R, Smeeth L, Tata LJ (2014). First Trimester Exposure to Anxiolytic and Hypnotic Drugs and the Risks of Major Congenital Anomalies: A United Kingdom Population-Based Cohort Study. Public Library of Science ONE 9(6):e100996.
https://doi.org/10.1371/journal.pone.0100996.
71. Haakstad LAH, Voldner N, Henriksen T, Bø, K (2009). Why do pregnant women stop exercising in the third trimester? Acta Obstetricia et Gynecologica Scandinavica 88(11):1267-1275. https://doi.org/10.3109/00016340903284901.
72. Lyerly AD, Mitchell LM, Armstrong EM, Harris LH, Kukla R, Kuppermann M, Little MO (2009). Risk and the pregnant body. Hastings Center Report 39(6):34-42. https://doi.org/10.1353/hcr.0.0211.
73. Nordeng H, Koren G, Einarson A (2010). Pregnant Women's Beliefs About Medications-A Study Among 866 Norwegian Women. The Annals of Pharmacotherapy 44(9):1478-1484. https://doi.org/10.1345/aph.1p231.
74. Vandenbussche FP, De Jong-Potjer LC, Stiggelbout AM, Le Cessie S, Keirse MJ. (1999). Differences in the valuation of birth outcomes among pregnant women, mothers, and obstetricians. Birth 26(3):178- 183. https://doi.org/10.1046/j.1523-536x.1999.00178.x.
75. Rowlands S (2011). Misinformation on abortion. European Journal of Contraception and Reproductive Health Care 16(4):233-240. https://doi.org/10.3109/13625187.2011.570883.